|
1
|
Saga K, Tamai K, Yamazaki T and Kaneda Y:
Systemic administration of a novel immune-stimulatory pseudovirion
suppresses lung metastatic melanoma by regionally enhancing IFN-γ
production. Clin Cancer Res. 19:668–679. 2013. View Article : Google Scholar
|
|
2
|
Purwar R, Schlapbach C, Xiao S, et al:
Robust tumor immunity to melanoma mediated by
interleukin-9-producing T cells. Nat Med. 18:1248–1253. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kronenberg M: Toward an understanding of
NKT cell biology: progress and paradoxes. Annu Rev Immunol.
23:877–900. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kronenberg M and Gapin L: The
unconventional lifestyle of NKT cells. Nat Rev Immunol. 2:557–568.
2002.PubMed/NCBI
|
|
5
|
Taniguchi M, Harada M, Kojo S, Nakayama T
and Wakao H: The regulatory role of Vα14 NKT cells in innate and
acquired immune response. Annu Rev Immunol. 21:483–513. 2003.
View Article : Google Scholar
|
|
6
|
Paget C, Chow MT, Duret H, Mattarollo SR
and Smyth MJ: Role of γδ T cells in α-galactosylceramide-mediated
immunity. J Immunol. 188:3928–3939. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tessmer MS, Fatima A, Paget C, Trottein F
and Brossay L: NKT cell immune responses to viral infection. Expert
Opin Ther Targets. 13:153–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tupin E, Kinjo Y and Kronenberg M: The
unique role of natural killer T cells in the response to
microorganisms. Nat Rev Microbiol. 5:405–417. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu L and Van Kaer L: Natural killer T
cells and autoimmune disease. Curr Mol Med. 9:4–14. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Perret R, Sierro SR, Botelho NK, Corgnac
S, Donda A and Romero P: Adjuvants that improve the ratio of
antigen-specific effector to regulatory T cells enhance tumor
immunity. Cancer Res. 73:6597–6608. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Salaun B, Coste I, Rissoan MC, Lebecque SJ
and Renno T: TLR3 can directly trigger apoptosis in human cancer
cells. J Immunol. 176:4894–4901. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Davis MB, Vasquez-Dunddel D, Fu J,
Albesiano E, Pardoll D and Kim YJ: Intratumoral administration of
TLR4 agonist absorbed into a cellular vector improves antitumor
responses. Clin Cancer Res. 17:3984–3992. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Spaner DE and Masellis A: Toll-like
receptor agonists in the treatment of chronic lymphocytic leukemia.
Leukemia. 21:53–60. 2007. View Article : Google Scholar
|
|
14
|
Ochi A, Graffeo CS, Zambirinis CP, et al:
Toll-like receptor 7 regulates pancreatic carcinogenesis in mice
and humans. J Clin Invest. 122:4118–4129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ito H, Koide N, Morikawa A, et al:
Augmentation of lipopolysaccharide-induced nitric oxide production
by α-galactosylceramide in mouse peritoneal cells. J Endotoxin Res.
11:213–219. 2005.
|
|
16
|
Ito H, Koide N, Hassan F, et al: Lethal
endotoxic shock using α-galactosylceramide sensitization as a new
experimental model of septic shock. Lab Invest. 86:254–261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ohtaki H, Ito H, Ando K, et al: Vα14 NKT
cells activated by alpha-galactosylceramide augment
lipopolysaccharide-induced nitric oxide production in mouse
intra-hepatic lymphocytes. Biochem Biophys Res Commun. 378:579–583.
2009. View Article : Google Scholar
|
|
18
|
Ando T, Ito H, Ohtaki H and Seishima M:
Toll-like receptor agonists and alpha-galactosylceramide
synergistically enhance the production of interferon-gamma in
murine splenocytes. Sci Rep. 3:25592013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hayakawa Y, Takeda K, Yagita H, et al:
Critical contribution of IFN-γ and NK cells, but not
perforin-mediated cytotoxicity, to anti-metastatic effect of
α-galactosylceramide. Eur J Immunol. 31:1720–1727. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Marth C, Fiegl H, Zeimet AG, et al:
Interferon-γ expression is an independent prognostic factor in
ovarian cancer. Am J Obstet Gynecol. 191:1598–1605. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakagawa Y, Watari E, Shimizu M and
Takahashi H: One-step simple assay to determine antigen-specific
cytotoxic activities by single-color flow cytometry. Biomed Res.
32:159–166. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Seki S, Nakashima H, Nakashima M and
Kinoshita M: Antitumor immunity produced by the liver Kupffer
cells, NK cells, NKT cells, and CD8+ CD122+ T
cells. Clin Dev Immunol. 2011:8683452011. View Article : Google Scholar
|
|
23
|
Smith SM and Dockrell HM: Role of
CD8+ T cells in mycobacterial infections. Immunol Cell
Biol. 78:325–333. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Exley MA, Lynch L, Varghese B, Nowak M,
Alatrakchi N and Balk SP: Developing understanding of the roles of
CD1d-restricted T cell subsets in cancer: reversing tumor-induced
defects. Clin Immunol. 140:184–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moreno M, Molling JW, von
Mensdorff-Pouilly S, et al: IFN-γ-producing human invariant NKT
cells promote tumor-associated antigen-specific cytotoxic T cell
responses. J Immunol. 181:2446–2454. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang D, Precopio M, Lan T, et al:
Antitumor activity and immune response induction of a dual agonist
of Toll-like receptors 7 and 8. Mol Cancer Ther. 9:1788–1797. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lim JY, Gerber SA, Murphy SP and Lord EM:
Type I interferons induced by radiation therapy mediate recruitment
and effector function of CD8+ T cells. Cancer Immunol
Immunother. 63:259–271. 2014. View Article : Google Scholar
|
|
28
|
Choi DH, Kim KS, Yang SH, et al: Dendritic
cell internalization of α-galactosylceramide from CD8 T cells
induces potent antitumor CD8 T-cell responses. Cancer Res.
71:7442–7451. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chang DH, Osman K, Connolly J, et al:
Sustained expansion of NKT cells and antigen-specific T cells after
injection of α-galactosyl-ceramide loaded mature dendritic cells in
cancer patients. J Exp Med. 201:1503–1517. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Andersson A, Yang SC, Huang M, et al: IL-7
promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung
cancer. J Immunol. 182:6951–6958. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wong JL, Berk E, Edwards RP and Kalinski
P: IL-18-primed helper NK cells collaborate with dendritic cells to
promote recruitment of effector CD8+ T cells to the
tumor microenvironment. Cancer Res. 73:4653–4662. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang P, Yang X, Xu W, Li K, Chu Y and
Xiong S: Integrating individual functional moieties of CXCL10 and
CXCL11 into a novel chimeric chemokine leads to synergistic
antitumor effects: a strategy for chemokine-based
multi-target-directed cancer therapy. Cancer Immunol Immunother.
59:1715–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wallace KL, Marshall MA, Ramos SI, et al:
NKT cells mediate pulmonary inflammation and dysfunction in murine
sickle cell disease through production of IFN-γ and CXCR3
chemokines. Blood. 114:667–676. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Müller M, Carter S, Hofer MJ and Campbell
IL: Review: the chemokine receptor CXCR3 and its ligands CXCL9,
CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and
conundrum. Neuropathol Appl Neurobiol. 36:368–387. 2010. View Article : Google Scholar
|
|
35
|
Rosenblum JM, Shimoda N, Schenk AD, et al:
CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic
costimulation molecules during the priming of alloreactive T cell
effectors. J Immunol. 184:3450–3460. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Takeshima T, Chamoto K, Wakita D, et al:
Local radiation therapy inhibits tumor growth through the
generation of tumor-specific CTL: its potentiation by combination
with Th1 cell therapy. Cancer Res. 70:2697–2706. 2010. View Article : Google Scholar : PubMed/NCBI
|
